Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on its optimism about the company's prophylactic treatment for Hereditary Angioedema...
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 3,653,310 | $91,150,085 | 0.24% | |
| 2. | Deerfield Management James E. Flynn | 2,442,464 | $60,939,477 | +22% | 0.93% |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 2,418,476 | $60,340,976 | +27% | 2.95% |
| 4. | Cormorant Asset Management Bihua Chen | 1,363,200 | $34,011,840 | -7% | 2.35% |
| 5. | Saturn V Capital Management Xiaoying Tian | 886,332 | $22,113,983 | 4.85% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,031,252 | $200,379,737 | 6.02% | |
| 2. | 6,399,158 | $159,658,992 | 0.01% | |
| 3. | 4,778,581 | $119,225,596 | 65.29% | |
| 4. | 4,639,304 | $115,750,635 | 65.62% | |
| 5. | 3,424,609 | $85,443,995 | 4.59% |